CPC A61K 31/519 (2013.01) [A61K 9/0053 (2013.01); A61K 9/0095 (2013.01); A61K 9/08 (2013.01); A61K 9/14 (2013.01); A61K 9/145 (2013.01); A61K 31/5025 (2013.01); A61K 31/575 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 2300/00 (2013.01)] | 47 Claims |
1. A dry granulated powder blend for an oral solution, said dry granulated powder blend comprising
7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one or a pharmaceutically acceptable salt thereof;
a stabilizer comprising disodium ethylenediaminetetraacetate;
an antioxidant comprising ascorbic acid; and
an acidifier comprising tartaric acid.
|